Cortalix

Netherlands
Ten Boer, Groningen, The Netherlands

Company profile

Cortalix company profile

Cortalix is a biotechnological company developing PET-imaging diagnostics, targeted radiotherapeutics, CAR-T immunotherapeutics, and diagnostics for novel targets based on its proprietary platform of synthetic single domain antibodies in close partnerships with companies.

Business identity

Operating status
Active
Company type
For Profit
Employee range
1-10 employees
Founded
2007-01-01, Year

Headquarters

Country code
NL
Continent
Europe

Capital profile

Funding and company signals

Funding stage
Seed
Funding rounds
1
Total equity funding
$1.1M
Last funding
Seed / $1.1M / 2025-03-10
Last equity funding
Seed / $1.1M
Investors
2
Lead investors
1
Founders
1

Founders and investors

Founders

Herman Steen

Lead investors

Future Tech Ventures

Investors

Future Tech VenturesRabobank